Medications & Supplements/Prescription Drugs

Northwind Pharmaceuticals Sulfamethoxazole and Trimethoprim Recalled

Agency Publication Date: September 17, 2025

Summary

Northwind Pharmaceuticals LLC is recalling 2,293 bottles of Sulfamethoxazole and Trimethoprim (800mg / 160mg) Double Strength tablets because a foreign micro-organism was found on the polyester coil used in the product's packaging. While no micro-organisms were detected on the actual tablets, the company is voluntarily recalling these specific lots out of caution. The affected medication was repackaged from Amneal Pharmaceuticals and distributed nationwide in 6, 10, 14, and 20-count bottles.

Risk

The presence of a micro-organism in the packaging material could potentially contaminate the medication, which may lead to infections or other adverse health effects if ingested.

What You Should Do

Check your prescription bottle for the following NDC codes: 51655-307-87, 51655-307-53, 51655-307-84, or 51655-307-20.
Verify if your bottle matches one of the affected lot numbers and expiration dates, such as F118062503 (Exp 05/31/2027), F118062423 (Exp 01/31/2027), or F118062512 (Exp 04/30/2027). See the Affected Products section below for the full list of affected codes.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength

Variants: 800mg / 160mg, Double Strength, 6-count bottle, 10-count bottle, 14-count bottle, 20-count bottle

Lot Numbers:

F118062503 (Exp 05/31/2027)

F118062507 (Exp 07/31/2027)

F118062504 (Exp 05/31/2027)

F118062505 (Exp 05/31/2027)

F118062509 (Exp 08/31/2027)

F118062512 (Exp 04/30/2027)

F118062506 (Exp 06/30/2027)

F118062423 (Exp 01/31/2027)

F118062501 (Exp 06/30/2027)

F118062502 (Exp 04/30/2027)

F118062508 (Exp 08/31/2027)

NDC:

51655-307-87

51655-307-53

51655-307-84

51655-307-20

Repackaged from Amneal Pharmaceuticals LLC; Quantity: a) 96 bottles, b) 627 bottles, c) 428 bottles, d) 1144 bottles

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 97544

Status: Active

Manufacturer: Northwind Pharmaceuticals LLC

Sold By: Retail Pharmacies

Manufactured In: United States

Units Affected: a) 96 bottles, b) 627 bottles, c) 428 bottles, d) 1144 bottles

Distributed To: Nationwide

Agency Last Updated: September 18, 2025

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

Check your prescription bottle for the following NDC codes: 51655-307-87, 51655-307-53, 51655-307-84, or 51655-307-20.

Verify if your bottle matches one of the affected lot numbers and expiration dates, such as F118062503 (Exp 05/31/2027), F118062423 (Exp 01/31/2027), or F118062512 (Exp 04/30/2027). See the Affected Products section below for the full list of affected codes.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength

Variants: 800mg / 160mg, Double Strength, 6-count bottle, 10-count bottle, 14-count bottle, 20-count bottle

Lot Numbers:

F118062503 (Exp 05/31/2027)

F118062507 (Exp 07/31/2027)

F118062504 (Exp 05/31/2027)

F118062505 (Exp 05/31/2027)

F118062509 (Exp 08/31/2027)

F118062512 (Exp 04/30/2027)

F118062506 (Exp 06/30/2027)

F118062423 (Exp 01/31/2027)

F118062501 (Exp 06/30/2027)

F118062502 (Exp 04/30/2027)

F118062508 (Exp 08/31/2027)

NDC:

51655-307-87

51655-307-53

51655-307-84

51655-307-20

Repackaged from Amneal Pharmaceuticals LLC; Quantity: a) 96 bottles, b) 627 bottles, c) 428 bottles, d) 1144 bottles

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 97544

Status: Active

Manufacturer: Northwind Pharmaceuticals LLC

Sold By: Retail Pharmacies

Manufactured In: United States

Units Affected: a) 96 bottles, b) 627 bottles, c) 428 bottles, d) 1144 bottles

Distributed To: Nationwide

Agency Last Updated: September 18, 2025